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PENILAIAN RAWATAN AKUPUNKTUR UNTUK PROSTATITIS KRONIK/ 
SINDROM SAKIT PELVIS KRONIK 
ABSTRAK 
 
Penyakit prostatitis kronik/ sindrom sakit pelvis kronik merupakan sejenis 
sindrom yang mengecewakan, mengelirukan dan kerap ditemui. Sebanyak  2 
juta orang dirawat untuk penyakit ini di Amerika Syarikat dan di Malaysia, 
penyakit ini dihidapi oleh 8.7% kaum lelaki. Hanya sejak 1995 penyakit ini 
mendapat perhatian perkhidmatan kesihatan di serata dunia. 
 
Walaupun sebab-sebab penyakit ini tidak diketahui, banyak rawatan 
seperti antibiotik, penghalang alfa serta ubat penahan sakit telah digunakan 
dengan kejayaan yang terhad. Ini mendorong para penyelidik untuk menyelidik 
penyakit ini dengan lebih terperinci. Kajian terbaru ini mencadangkan bahawa 
akupunktur adalah amat berguna terutamanya untuk kes-kes yang kronik.  
 
Untuk mengesahkan keberkesanan rawatan, borang soal-selidik  “Brief 
Pain Inventory” dan “Hospital Anxiety Depression Scale”  digunakan dan borang 
tersebut disahkan benar. Dalam kajian yang seterusnya, rawatan serta 
diagnosis penyakit prostatitis oleh doktor telah disoal-selidiki. Didapati bahawa 
pesakit prostatitis biasanya tidak mendapat rawatan optimum untuk penyakit 
mereka, mengukuhkan keperluan kajian ini. 
 
 
 
 xxix
Simptom-simptom serta maklumat peribadi pesakit yang menghidapi 
penyakit prostatitis kronik dikaji untuk memahami penyakit ini serta kesan-
kesan terhadap taraf kesihatan dengan lebih mendalam. Lelaki yang 
menghidapi penyakit ini didapati mempunyai masalah sakit, kencing, fungsi 
seks serta mental. Selain itu, didapati bahawa simptom mereka adalah sama 
seperti pesakit di Amerika. 
 
Akhirnya, subset pesakit yang menghidapi penyakit dijemput untuk 
menyertai kajian secara rambang, dengan plasebo menggunakan akupunktur 
untuk merawat penyakit prostatitis kronik. Pesakit dirawat 2 kali seminggu untuk 
10 minggu dengan akupunktur ataupun plasebo. Akupunktur di dapati berkesan 
untuk 32 (73%) daripada 44 pesakit manakala plasebo di dapati berkesan untuk 
21 (47%) daripada 45 pesakit  (p=0.01).   
 
Ketika rawatan, pesakit juga menilai tahap sakit serta penerimaan  
rawatan mereka terhadap akupunktur, untuk mengetahui jikalau hasil kajian 
dapat digunakan bagi penduduk negara ini. Akupunktur mudah diterima oleh 
kebanyakkan pesakit yang menyertai  kajian ini. Dalam pada itu juga, sampel 
darah diambil untuk mendapatkan satu penerangan secara saintifik bagi 
akupunktur.  Tahap -endorphin, leucine-enkephalin serta kortisol didapati 
sama untuk kedua-dua kumpulan pesakit tetapi terdapat perubahan dalam 
tahap sel darah putih, mencadangkan fungsi imun dalam penyakit ini. 
 xxx
EVALUATION OF ACUPUNCTURE THERAPY FOR CHRONIC 
PROSTATITIS/ CHRONIC PELVIC PAIN SYNDROME 
 
ABSTRACT 
 
Chronic prostatitis/ chronic pelvic pain syndrome is a frustrating, 
confusing and prevalent syndrome. It accounts for nearly 2 million visits to the 
physicians annually in US, and in Malaysia, is known to affect the lives of 
approximately 8.7% of the male population. As recent as 1995, only did this 
syndrome gain the attention of healthcare providers worldwide. 
 
While the causes of chronic prostatitis/ chronic pelvic pain syndrome 
remain unknown, many therapies have been used with limited success, the 
most common being antibiotics, alpha-blockers and anti-inflammatories. This 
prompted many to search for more effective therapies and recent studies 
suggest that acupuncture may be helpful especially in chronic cases. 
 
Prior to conducting the study, the validity of 2 questionnaires used to 
evaluate the efficacy of treatment outcomes were examined in the local 
population. The Brief Pain Inventory and Hospital Anxiety Depression Scale 
were demonstrated to have good reliability and validity as an outcome measure. 
In the next part, the diagnosis and treatment of prostatitis-like symptoms by 
primary care physicians were examined. It was found that many patients with 
prostatitis like symptoms were receiving less than optimal treatment for their 
condition, further strengthening the need for this study. 
 xxxi
To achieve a better understanding of this condition and the health status 
impact on men, the baseline demographics and clinical characteristics of men 
with chronic prostatitis were evaluated. It was concluded that men experienced 
disability in the various domains of pain, urinary, sexual function and mental 
health. The demographics of these participants were similar to those in the 
United States.  
 
Finally, a subset of participants were invited to participate into a 
randomised, double-blind,  sham controlled study involving acupuncture or its 
corresponding placebo for the treatment of chronic prostatitis. These 
participants were treated twice weekly for a total of 10 weeks with acupuncture 
or sham. Thirty-two (73%) of 44 participants responded in the acupuncture 
group compared to 21 (47%) of 45 participants who responded in the sham 
group (p=0·01).    
 
To determine the applicability of these results in the general population, 
participants also rated the tolerability and acceptability of acupuncture 
treatment. Acupuncture was found to be tolerable by majority of participants. 
Blood samples were also taken to elucidate a scientific explanation for the 
response of participants. The levels of neurotransmitter -endorphin, leucine-
enkephalin and cortisol were mostly similar between groups but changes in the 
white cell levels were observed suggesting the role of immune function in the 
pathogenesis of this disease.  
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CHAPTER 1 PROSTATITIS  
 
1.1 INTRODUCTION 
 
 
Prostatitis is a major healthcare problem for men. It is one of the most 
common urological disorders in young men aged 20 and above, accounting for 
almost 2 million physicians visits a year in the United States (McNaughton 
Collins et al., 1998). Recent epidemiological studies have shown that prostatitis 
afflicts 2-10% of the population worldwide, with a prevalence of 8.7% in 
Malaysia (Krieger et al., 2003, Cheah et al., 2003a). This disease is 
characterised mostly by chronic pelvic pain accompanied by variable 
disturbances in voiding and sexual life. 
 
During the last ten years, a new and more appropriate clinical 
classification of prostatitis was proposed by the National Institutes of Health 
(NIH) (Krieger et al., 1999). This was followed by the NIH-Chronic Prostatitis 
Symptom Index (NIH-CPSI) for measuring the severity of symptoms in 
prostatitis patients in May 1999 (Litwin et al., 1999).  More recently, a second 
initiative have also been established by the National Diabetes and Diseases of 
Kidney (NIDDK) of the NIH to search for a treatment for prostatitis and also to 
elucidate its aetiology. 
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1.2 BASIC ANATOMY, HISTOLOGY AND PHYSIOLOGY RELATED TO 
THE PROSTATE GLAND  
 
The prostate gland consists of 2 parts, the fibro-muscular glandular part 
and the stroma. It has the shape of a pyramid and lies on the pelvic 
musculofascial floor, being surrounded by a thin layer of connective tissue 
(Dixon et al., 1999). The gland has a base and an apex, anterior and posterior 
surfaces and two infero-lateral surfaces. The base is connected to the bladder 
neck and the apex is surrounded inferiorly by the external sphincter, all forming 
together the proximal urethra, the main continence mechanism in the male 
(Figure 1.1). The prostate is separated posteriorly from the rectum by the 
anterior layer of Dennonvillier’s fascia and is fixed anteriorly to the pubic bone 
with the puboprostatic ligaments, being held in the dorsal vein plexus between 
these structures. A thin layer of connective tissue forms the “true” capsule in the 
periphery of the prostate, outside of which the pelvic fascia forms the “false” 
capsule (Dixon et al., 1999). 
 
The main arterial supply to the prostate gland is from the prostatic 
branches of the inferior vesical artery, and it is also supplied by small branches 
from the middle rectal and pudendal vessels. The veins are situated mainly 
between the “true” and “false” capsules. The lymphatic vessels from the 
prostate gland drain into internal iliac lymph nodes (Dixon et al., 1999). 
 
The prostatic urethra is about 3cm long and two ejaculatory ducts (one or 
two orifices) open in the colliculus seminalis (or verumontanum) near the 
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external sphincter. Histologically, the prostate gland can be divided into three 
parts. 
 
 The peripheral zone which forms about 70% of glandular prostate 
 
 The central zone forms about 25% of the glandular prostate 
 
 The transitional zone (about 5%) consists of two small lobes  
 
The human prostate gland receives dual autonomic innervations from both 
parasympathetic (cholinergic) and sympathetic (noradrenergic) nerves in the 
prostatic nerve plexus. The pelvic plexus receives its parasympathetic input 
from the sacral segments of the spinal cord (S2-4) and sympathetic fibres from 
the hypogastric presacral nerves (T10-L2). Both cholinergic and noradrenergic 
fibres innervate the prostate stroma, and cholinergic nerves innervate the 
smooth muscle of the capsule and the space around the blood vessels and are 
responsible for the secretory function of the epithelial part. The symphathetic 
nerve control the prostatic musculature, and their excitation closes the bladder 
neck during ejaculation of the seminal fluid into the urethra (Dixon et al., 1999). 
 
The ejaculate from the human prostate is a slightly acidic (pH 6.5), serous 
fluid in which several major secretory products can be identified, notably acid 
phosphatase, citrate, zinc, soluble fraction proteins, carbohydrates, electrolytes, 
polyamines, hormones, lipids and growth factors. (Weidner et al., 1991, 
Zaichick et al., 1996) 
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Up to 57 major protein groups, of which 27 is non-serum proteins have been 
identified. Major prostate-specific proteins are prostatic acid phosphatase 
(PAP), prostate specific antigen (PSA) and prostate binding protein (PBP), 
which are expressed at pubertal and adult ages. Proteolysis is the major 
function of prostate secretion, being rich in exopeptidase and endopeptidase. 
The most extensively studied protease is PSA, also known as seminin, seminal 
protease or chymotrypsin-like protease (Neal et al., 1992, Dixon et al., 1999) 
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Figure 1.1: The prostate gland consists of 3 different zones, a central zone, a 
peripheral zone and a transitional zone. The peripheral zone is usually the site 
for development of prostate cancer while transitional zone is the site for 
development of benign prostatic hypertrophy. However, the same analogy 
cannot be distinguished for prostatitis. (Adapted from Kirby and McConnell, 
2002) 
Prostatic urethra 
Ejeculatory duct 
Peripheral zone 
Central zone 
Transitional zone 
Fibromuscular  
zone 
Periurethral 
gland region 
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1.3 EARLY CLASSIFICATION OF PROSTATITIS  
 
The pathology of prostate diseases was initially described only as acute 
prostatitis, a complication of either acute septic invasion of the prostate by 
bacteria or chronic inflammation of the prostate. In the 1920s, von Lackum 
classified prostatitis into active, latent and bacterial types, the aetiology of the 
disease being determined only by microbiological culture (von Lackum, 1927). 
 
Later, prostatitis was divided into two main groups according to their 
bacterial aetiology: a primary group- after gonorrhoeal infection (three types: 
simple, true and atopic prostatitis), and a secondary group – without proven 
gonococcus termed the focal type of prostatitis, based on the focal infection 
theory that attracted much attention among researchers. In 1938, Grant 
proposed that the classification be divided into 3 types: acute, occluded chronic 
and recalcitrant prostatitis, where the latter denoted persistent infection after the 
failure of treatment. 
 
It was not until the publication by Meares and Stamey (1968) concerning 
suggestion for diagnosing prostatitis by the “four-glass test” that led to the 
proposal of a traditional classification of prostatitis by Drach et al in 1978. 
Inflammation of the prostate gland was defined on the basis of finding 
leukocytes in the prostatic fluid. Based in this description, the traditional 
classification is illustrated in Table 1.1. 
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Table 1.1: The traditional classification of prostatitis first proposed by Drach et 
al in 1978.  
 
 
 
Category 
 
 
Classification 
 
Description 
 
I 
 
Acute bacterial prostatitis 
 
Acute infection of prostate 
II Chronic bacterial prostatitis Significant infection (>103 cfu) 
of bacteria recovered in EPS 
 
III Chronic non-bacterial prostatitis Absence of bacteria but 
significant number of leukocytes 
(>10 per hpf) in EPS 
 
IV Prostatodynia No signs of bacteria or 
inflammation in prostate 
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Acute bacterial prostatitis: Recommendations are to avoid massage of the 
prostate gland, and the diagnosis is based on culture and detection of a 
swollen, tender prostate in rectal examination. Signs of general illness (fever, 
chills and malaise) with history of urinary tract infection are present.  
 
Chronic bacterial prostatitis: Diagnosis is confirmed when pathogenic 
bacteria are recovered from the prostatic fluid in significant numbers (>103), a 
urine culture is negative and may be positive, and there are no signs of 
systemic infection 
 
Chronic non-bacterial prostatitis: No bacterium is found in the prostatic fluid 
but a significant number of leukocytes (>10 per hpf) are seen. Drach et al 
(1978) pointed the possibility of cryptic/hidden infections through Trichomonas, 
fungi, Chlamydia or Mycoplasma. 
 
Prostatodynia: Consistent pain in the prostate (pelvic pain). Diagnosis is 
preferred when there are no bacteria or signs of inflammation (leukocytes) in 
the prostatic fluid. 
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1.4 THE NEW NATIONAL INSTITUTES OF HEALTH (NIH) 
CLASSIFICATION OF PROSTATITIS  
 
 
In December 1995, the NIH Workshop on Chronic Prostatitis and the 
NIH-supported International Chronic Prostatitis Collaborative Research Network 
(ICPCN) in Washington proposed a new classification for diagnosing and 
characterizing prostatitis. The new definition recognizes that pain is the leading 
symptom of chronic prostatitis, together with a wide range of voiding, 
psychological and sexual disturbances. This classification, presented in Table 
1.2, was later accepted by urologist and validated by a number of university 
clinics and published for clinical use in 1999 (Krieger et al., 1999). 
 
The new classification system is based on results of microscopic and 
bacterial culture of the expressed prostate secretion (EPS), semen culture, 
post-massage urine and biopsy of prostate gland. As shown in Table 1.2, 
clinical categories I and II are as in the previous classification of Drach et al 
(1978). The main differences are in clinical category III, which is divided into 
subcategories A and B, chronic prostatitis/chronic pelvic pain syndrome 
(CP/CPPS) with or without signs of inflammation (leukocytes > or < 10 per hpf). 
Additionally, category IV was included, defined as patients with histologically 
proven chronic prostatitis without clinical symptoms of pain and/or diseases at 
all. 
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Table 1.2: The new NIH consensus classification of prostatitis. It was developed 
based on microscopic and bacterial culture and recognises that in some cases, 
prostatitis may occur in asymptomatic patients 
 
 
  
Category 
 
Designation 
 
Infection status 
 
   
        I Acute bacterial prostatitis Acute infection of the prostate 
       II Chronic bacterial 
prostatitis 
Recurrent infection of the prostate 
      III Chronic prostatitis/ 
Chronic pelvic pain 
syndrome 
Discomfort or pain in the pelvic 
region. Variable voiding and sexual 
symptoms with no demonstrable 
infection 
 
      IIIa Inflammatory Leukocytes in semen, expressed 
prostatic secretions (EPS), or voided 
bladder urine-3 (VB-3). 
 
      IIIb Non-inflammatory No leukocytes in semen, EPS and  
VB-3 
       IV Asymptomatic 
inflammatory prostatitis 
No subjective symptoms detected but 
leukocytes are found in prostate 
secretions or in prostate tissue during 
an evaluation for other disorders. 
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Unfortunately, this classification still has some limitations, largely due to 
our inadequate understanding of the relevance of white blood cells, lack of 
standardisation of leukocyte investigation techniques and the lack of 
comparable cut-off points for elevated number of leukocytes in the EPS and/or 
semen (Krieger et al., 2000a, Krieger et al., 2000b).  Most problems are related 
to the lack of understanding of the relevance and importance of 
fastidious/cryptic microorganism. All said, this new classification system is a 
clear improvement over the old one, brings more effectiveness and clarity into 
clinical practice and research protocols. 
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1.5 PRACTICAL CLINICAL PRACTICE PATTERNS IN PROSTATITIS   
 
The first investigation into practical patterns related to prostatitis was 
published by de la Rosette et al (1992), containing information on prostatitis 
among patients seen by primary care physicians and urologist. This study 
pointed out three main discrepancies: that physician see older patients than 
urologist, that physicians see only a tenth of the number of patients that 
urologist do, and that physicians mainly think that the aetiology of prostatitis is 
infectious, whereas urologist consider non-infectious causes most important. At 
least half of the physician and urologist think that it is very important to take 
note of the psychic component of chronic prostatitis. Half of the urologists 
perform EPS and semen culture for diagnostic purposes and treatment consists 
of one or more courses of antibiotics, analgesics and some supportive advice.  
 
Many other authors (Moon, 1997, Nickel et al., 1998) also reported 
similar results with regard to the opinions of physicians and urologist. These 
surveys show quite remarkable consistency from country to country, but the 
differences in the number of patients seen by doctors mainly represent the 
differences between health care services rather than diagnosis. 
 
These surveys (de la Rosette et al., 1992, Moon, 1997, Nickel et al., 
1998) also show that the use of antibiotics without any reason or any evidence 
of bacteria in the prostatic fluid and/or urine is the norm rather than the 
exception. It represents largely accepted behaviour and is supported by results 
of Berger et al (1997) concerning “cryptic infection” of the prostate gland. 
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The textbooks of urology presume that acute and chronic bacterial 
prostatitis are easily defined, diagnosed and treated (Meares, 1993). 
Fortunately, even when no prostatic fluid culture is performed, the use of one or 
more courses of antibiotics will generally elicit a therapeutic response. Category 
III patients are a problem to diagnose and treat, as inflammation may or may 
not be present (Krieger et al., 2000b). Additionally, when about 90% of bacterial 
cultures are negative this causes a normalising tendency, or clinical behaviour 
designed to avoid proper laboratory diagnostic in clinical practice, leading to an 
erroneous basis for reaching treatment decisions.  
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1.6 AETIOLOGY AND PATHOGENESIS OF PROSATITIS 
 
Even as we advance into the 21st century, the specific cause of most 
cases of non-acute prostatitis is unknown. Likewise, important aspects 
concerning the route of possible infection and pathogenesis remains uncertain 
in clear instances of bacterial prostatitis (Krieger, 1984, Krieger and Riley, 2002) 
 
Currently, four aetiological reasons for the induction of prostate 
inflammation are generally accepted, and the recovery or chronicity of the 
process depends on balances or imbalances between predisposing factors 
and/or host defence mechanisms (Figure 1.2). 
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Figure 1.2 Possible interplay of immunological, endocrine, chemical, 
neurological and psychological factors which may play a role in the 
development of CP/CPPS (Adapted from Pontari and Ruggieri, 2004) 
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1.6.1 Microbiological aspects of prostatitis 
 
 
It is essential to be able to demonstrate bacteria reliably in the EPS, 
semen or both in order to reach the correct treatment decision and to ensure a 
good outcome. Laboratory findings have shown that in practice almost all 
standard localisation cultures are negative and that success in culturing bacteria 
from the EPS is complicated by the presence of inhibitory substances known to 
exist in prostate secretion and by a history of multiple previous course of 
antibiotics (Nickel and McLean, 1998). 
 
Clear confirmation of the pathogenicity of bacteria in prostate tissue 
and/or ducts has been obtained with a group of gram-negative uropathogens 
including E. coli, Klebsiella spp., Serratia and Pseudomonas spp. (Meares and 
Stamey, 1968, Domingue and Hellstrom, 1998). Possible temporary pathogens 
in prostate tissue and/or ducts under certain conditions can be : coagulase-
negative Staphylococcus species, Chlamydia, Ureaplasma, Candida and 
Trichomonas (Potts et al., 2000, Nickel, 2000). Acknowledged not to be 
pathogens so far are: Diptheroidds, Lactobacilli and Corynebacteria spp. 
(Domingue and Hellstrom, 1998, Nickel, 2000) 
 
A number of prostatitis studies provide some support for a new concept, 
the use of immunochemistry, electron microscopy, and ultrasensitive molecular 
PCR methods for detecting bacteria or their remnants in prostate tissue, 
implying that at least the majority of patients with prostatitis, and perhaps all of 
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them, have a microbiological cause for their symptoms (Domingue and 
Hellstrom, 1998, Terai et al., 2000, Krieger et al., 2000c). 
 
Last but not least, it must also be mention that cryptic non-culturable 
organisms such as altered ‘biofilm forming colonies’, viruses and cell wall-
deficient bacteria, the importance of which for the immune system of the host is 
not finally clear (Arakawa et al., 1993, Domingue and Hellstrom, 1998)  
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1.6.2 Immunological aspects of prostatitis 
 
The secretory immune response is an essential factor in helping the 
mucosal barrier to resist bacterial invasion into the glandular-epithelial system 
of the prostate gland. The prostate secretes local antibodies in response to 
infection or the remnants of bacterial protein, in which this local response is 
often different from systemic ones reflected in the serum findings. The amounts 
of immunoglobulin G and A (IgG and IgA) have been found to be much lower in 
normal human prostatic fluid than in patients with prostatitis. It thus appears that 
measurements of antigen-specific IgA and IgG levels in the prostatic fluid can 
be helpful in the diagnosis of prostatitis and in determining the possible 
response to long-term courses of antibiotics in patients with a confirmed 
aetiology (Shortliffe et al., 1981, Fowler and Mariano, 1984, Kumon, 1992) 
 
The most common aetiological factor having a strong immunological 
effect on the secretion of antigen-specific IgA into the prostatic fluid, 
independent of the systemic immune response, is E. coli and very occasionally 
certain Enterococcus species, while the role of staphylococci being more 
questionable (Fowler and Mariano, 1984). 
 
On the other hand, Nickel and Costerton (1993) showed cultures from 
prostate tissue that coagulase-negative staphylococci formed focal 
microcolonies that adhered to the walls of the prostatic ducts and were 
protected with glycocalyxlime and deduced that it was not the bacteria 
themselves that led to tissue damage but the immune-mediated inflammation.  
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Typical over-reaction of the host response and delayed hypersensitivity 
reactions are represented by inflammatory infiltrates from T-lymphocytes (CD4+ 
T helper/ inducer cells and CD8+ T cytotoxic/suppressor cells), which are 
distributed variously between the epithelial and stromal components. This can 
be due to intraprostatic spermatozoa intrusion, which is known to have a 
powerful autoimmunization capacity and activity in some cases (McClinton et 
al., 1990). It has been shown in autopsy material that sperm may penetrate into 
the somatic cells and that this can produce tissue changes similar to those 
induced by a variety of carcinogens in experiments performed with human 
tissue. This phenomenon was confirmed by (Alexander et al., 1997) who 
showed that the CD4/ T cell proliferative response to seminal plasma was 
significant in cases of CP/CPPS as compared with normal men. Ponniah et al 
(2000) showed that some men with symptoms of chronic prostatitis have 
evidence of a proliferative CD4/ T cell response to PSA, one antigen candidate 
for possible autoimmune prostatitis while others have confirmed that T-
lymphocytes have a role in the excretion of inflammatory mediators such as 
complements C3, C4, and IL6 in the serum and ejaculate (John et al., 2001). 
They also found an increase in IgA in the ejaculate. The concentrations of these 
markers decreased with the relief of prostatitis symptoms. 
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1.6.3 Chemical and functional disorder aspects of prostatitis 
 
 
Persson and Ronquist (1996) studied the chemical composition of EPS 
and urine, showing that the origin of the chemical reaction and the basis for 
tissue inflammation was reflux into the prostatic ducts. Analogical findings were 
described by Ramirez et al (1980) showing that prostatic calculi are partly 
composed of the remains of ingredients coming from the urine reflux. 
 
If prostatic ducts are obstructed by calculi, there may be a mechanical 
reaction on the epithelia through rising intraductal fluid pressure or direct 
irritation from calculi and age can also be a co-relating factor (Ramirez et al., 
1980).  
 
Most patients with prostatitis have been shown to have an abnormal 
flowmetry parameters and distinct flow patterns (Ghobish, 2002). Thus, 
measurements of urine flow rate should be an integral part of the evaluation of 
prostatitis patients, as recommended by the current guidelines issued by the 
ICPCN in 1999 (Nickel, 2002). Synchronous video-pressure flow studies using a 
triple-lumen catheter with synchronous electromyography of the external 
urethral sphincter have demonstrated increased maximal urethral closure 
pressure in the proximal prostatic and membranous urethral segments as 
compared to controls (Barbalias et al., 1998) and also decreased maximum and 
average flow rates. These findings were originally confirmed in patients with 
prostatodynia, but identical observation were made in patients with an 
inflammatory prostate (Barbalias, 1990) causing the author to abandon the term 
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prostatodynia in favour of “painful urethral syndrome”. It was concluded that the 
findings could be attributed to a symphathetically mediated spasm. 
 
Increased pressure in the prostatic urethra causes reflux into the 
prostatic ducts and ejaculatory ducts accompanied by prostate tissue irritation. 
Thus, it would be appropriate to perform video-urodynamic assessment to rule 
out possible neurological reasons for voiding disturbances and/or to validate 
any findings of organic causes of  lower urinary tract symptoms (LUTS) and 
recurrent symptoms of CP/CPPS, thus also exploring the indication for alpha-
blocker treatment (Kaplan et al., 1997, Barbalias et al., 1998)   
 
An irony is that until now, it is unclear which came first: anatomical 
structural changes or functional disorder. It may be that reflux comes first, 
leading to chronic inflammation, upon which local reaction and tissue pressure 
leading to voiding disturbances with more reflux of urine, sterile or infection 
(Persson and Ronquist, 1996, Barbalias, 2002).   
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1.6.4 Myalgia aspects of prostatitis 
 
 
Some patients with CP/CPPS may also appear to suffer mainly from 
tension myalgia of the pelvic floor and symptoms thought to arise from habitual 
contraction or spasm of the pelvic floor muscles (Barbalias, 2002). Patients 
report pain and discomfort associated with sitting, running or other physical 
activity that lead to spasms in the perineal muscles. It is possible that a rectal 
examination may demonstrate a spastic anal sphincter and paraprostatic 
tenderness, but not a tender prostate at all (Lillius and Valtonen, 1972, Segura 
et al., 1979, Potts, 2003) 
 
Alternatively, CP/CPPS is thought to be caused by the compression 
neuropathy of the pudendal nerve. The bony remodeling as a result of the 
activity of pelvic floor muscles lead to juxtaposition of the sacrospinal and 
sacrotuberal ligaments, which compress the pudendal nerve in the narrowed 
interligamentous space. (Antolak et al., 2002) 
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1.6.5 Psychological aspects of prostatitis 
 
 
Psychological factors are considered to play an important role in the 
aetiology of CP/CPPS even as early as the late 1960s and the 1970s. 
Urological patients with prostatitis generally tend to exhibit psychiatric problems, 
and there is a widely held belief among urologist that these patients are 
“neurotic”. On this regard, CP/CPPS patients are often characterised as having 
problems with their male sexual identity. Symptoms such as anxiety, 
depression, fear, sexual disturbances and feeling of insecurity in human 
relationship especially psychological stress are common findings. Similarly, 
psychosomatic factors were found to be impaired (de la Rosette et al., 1993, 
Egan and Krieger, 1994). 
 
Thus, psychological evaluation, relationship counseling and even 
medical treatment for depression may play an important role in the overall 
approach to chronic prostatitis patients. This is in some cases obligatory in 
order to achieve any improvement in the symptoms or to avoid worsening of the 
mental distress (Egan and Krieger, 1994, Berghuis et al., 1996). 
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1.7 DIAGNOSTIC PROCEDURE OF PROSTATITIS  
 
 
To correctively evaluate a patient with prostatitis is an extremely 
complicated task, because the disease is defined only in terms of subjective 
symptoms with no objective, measurable parameters to divide the patients into 
diagnostic categories for clearly defined modes of treatment. Pain and 
discomfort is the most severe and common symptom, usually occurring in the 
region of the lower abdomen or more specifically at the suprapubic, perineal, 
scrotal, inguinal and penile areas (Figure 1.3). They can be accompanied by 
voiding complaints of varying severity and related symptoms. Temporary sexual 
dysfunction and mental distress may also be present in these patients. 
 
The baseline information should be obtained by taking a complete 
medical history of all the facts related to urinary tract infections and any 
previous history of possible sexually transmitted diseases and relating this to 
the number of sexual contacts. A previous history of urological procedures can 
provide some explanations on which to base a clinical conclusion, and similar 
importance can be given to co-morbidity factors reflecting on the host defense 
mechanism and haematuria which may require cystoscopy and urinary tract 
imaging. 
 
Clinical examination should focus on a careful assessment of the 
patients’ inguinal regions and scrotum for hernias and varicocele, penis for 
plaques suggestive of Peryronie’s disease or epididymoorchiditis, which can 
cause pain in the penis, a  careful  inspection  of  the  perineum for  evidence  of  
